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Effectiveness of Functional Electrical Stimulation - 




The purpose of  this study was to evaluate the effects of  functional electrical stimulation (FES) bicycle therapy system on motor 
function, gait pattern, spasticity, daily living activities, and aerobic capacity in children with cerebral palsy (CP) and to compare the 
results with sham stimulation and standard treatment.
Methods
Patients with cerebral palsy who received botulinum toxin type-A injections to lower extremities and those with Gross Motor Function 
Measure Classification System (GMFCS) levels I – III, were included in the study. Twenty-five patients were randomly assigned into 
three treatment groups for 4-weeks:  Group 1, FES-cycling and standard treatment; Group 2, Sham stimulus FES-cycling and standard 
treatment; Group 3, Standard treatment. Clinical assessment tools included the Modified Ashworth Scale (MAS), Modified Tardieu 
Scale (MTS), Pediatric Functional Independence Measure (WeeFIM), GMFCS, Gross Motor Function Measure-88 (GMFM-88), 
selective motor control tests, 6-minute walk test, and Visual Gait Analysis (VGA).
Results
In all groups, there were significant improvements in MAS, MTS, WeeFIM, GMFM-88, 6-minute walk test, and VGA scores. No 
changes in GMFCS levels were observed in any group. At the end of  the study, there was no significant difference among the groups 
in terms of  any clinical assessment parameter.
Conclusions
All groups showed statistically significant improvements in motor function, walking pattern, spasticity, daily living activities, and aerobic 
capacity in patients with CP following the rehabilitation period. Although FES-cycling demonstrated no superiority over the other 
approaches and provided no additional benefit to the results, FES appears to be safe and well-tolerated in children with CP, at least as 
much as standard exercise treatment.
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Introduction
Cerebral palsy (CP), one of  the most frequent causes of  
childhood disability, is a nonprogressive motor dysfunction 
that affects muscle tone, posture, and movement. Although 
the disorder itself  is not progressive, the clinical expression 
may change over time as the musculoskeletal and the central 
nervous system matures. The motor impairment generally 
results in limitations in functional abilities and activity 1.  One 
of  the aims of  the CP treatment is to increase their functional 
capacity as much as possible 2. Although Rehabilitation of  CP 
has performed by rehabilitation professionals for a long time, 
many new treatment methods have emerged in recent years. 
Although Botulinum toxin is a commonly used and effective 
treatment method for reducing spasticity in CP, it is not a 
single-handed practice, but rather one part of  a multi-faceted 
rehabilitation program. The reduction in spasticity after 
botulinum toxin injections provides a therapeutic window 
for patients with CP 3. For those able to participate, aerobic 
exercises decrease the energy consumption for ambulation 
and increase muscle strength, gross motor function, and 
for those able to use such equipment motivation, ultimately 
helping people feel better 4. Such exercises include voluntary 
and coordinated movements that are repetitive and reciprocal 
5. Equipment such as treadmill, bicycle (for those able to 
use such equipment), and upper limb ergometer is therefore 
used and increase the aerobic capacity of  the whole body 
and local muscles 6. Cycling is an exercise that challenges 
the muscular and cardiovascular systems and potentially 
leads to improved health, fitness, and well-being. Cycling 
with functional electrical stimulation (FES) has been used 
primarily for people with spinal cord injury; improvements 
in bone mineral density, muscle strength (force-generating 
capacity), and cardiorespiratory measures were observed 
7. FES-cycling is a relatively new technology, and very few 
studies have been conducted on the effect of  this method in 
children with CP8,9,10. 
The present study aimed to evaluate the effects of  FES-
cycling therapy on motor function, walking pattern, spasticity, 
daily living activities, and aerobic capacity in patients with CP. 
Methods 
Participants
The present study included patients who were between 4 to 
12 years old, diagnosed with diplegic CP, and GMFCS levels 
I to III, and received botulinum toxin type-A injections to 
the hamstring and gastrocnemius muscle groups every 6-9 
months as needed. The approval of  the study protocol was 
obtained from the local ethics committee of  the University 
of  Health Sciences, Dışkapı Yıldırım Beyazıt Training and 
Research Hospital, and written informed consent was 
obtained from the parents of  the children. The study was 
conducted by the principles of  the Declaration of  Helsinki11.
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Children who had limited ability to cooperate, diagnoses 
of  athetoid or ataxic CP,  undergone orthopedic surgery, 
vasomotor instability (coagulation disorder), lower motor 
neuron disorder, limitation/instability/dislocation of  the 
hip-knee joints, severe spasticity (Modified Ashworth 
Scale (MAS) > 3), pressure ulcer/skin loss in the area of  
a stimulation point, or uncontrolled epilepsy were excluded 
from the study. 
The demographic and clinical characteristics of  the patients 
were recorded. Patients were divided into 3 groups and 
randomized by sealed envelope method 12; Group 1 (n=9) 
comprised patients receiving FES-cycling and standard 
treatment; Group 2 (n=9) comprised patients with sham 
stimulus FES-cycling and standard treatment; Group 3 
(n=7) comprised patients receiving standard treatment alone. 
Numbers 1, 2 and 3 were written inside the envelopes for 
three groups and were prepared 9x3=27 of  these envelopes. 
Two patients in the group with standart treatment dropped 
out of  the study due to medical problems. As a result of  it 
the study was finished with 7 patients in one group and 9 
patients in two other groups.
Outcome Measures
Ankle and knee flexor spasticity was assessed using the 
Modified Ashworth Scale (MAS) and the Modified Tardieu 
Scale (MTS) 13,14.  All of  the measurements were taken in 
the supine position, the head position was in midline and 
the resting limb position was neutral. The scores for MAS 
were determined according to the level of  resistance during 
the passive movement of  the antagonist muscles. MTS was 
measured at 2 different velocities; XV1- slow as possible, 
slower than the gravitation force and natural fall, XV3- 
moving as fast as possible, faster than the gravitation force 
and natural fall. 
In the evaluation of  motor and functional status, Pediatric 
Functional Independence Measure (WeeFIM), Gross Motor 
Function Classification System (GMFCS)15, Gross Motor 
Function Measure-88 (GMFM-88)15,16, visual gait analysis, and 
selective motor control (SMC) tests17 were used. 
Pediatric Functional Independence Measure (WeeFİM) was 
also used for daily living activities evaluation18.
Selective motor control was performed to evaluate the 
voluntary motor control of  the ankle dorsiflexor muscles. 
The examiner first demonstrates the task by passively moving 
the limb, then the patient who was in the supine position, 
was asked to bring the ankle to dorsiflexion. It was scored 
from 0 to 4 (0: no active movement, 1: limited dorsiflexion, 
2: dorsiflexion using extensor hallucis longus and extensor digitorim 
longus activity, 3: dorsiflexion accompanied by hip and/or 
knee flexion, 4: selective dorsiflexion of  the ankle). 
The visual gait analysis was performed to all patients by 
video recording and used the anterior, posterior, and lateral 
planes. During the video recording the children were walking 
barefoot or with orthoses at a self-selected speed along a 
10m walkway. The visual gait analysis results were recorded 
according to the hip, knee, and ankle joint positions during 
walking using the Physician Rating Scale (PRS) (Table 1 )19. 
The 6-minute walk test was performed to assess aerobic capacity20. 
Before the test all the children were explained the rules of  
the test. For the test, it was used a 10m straight corridor, with 
a flat hard surface, free of  obstacles.  The distance covered 
by a child was recorded by a physiatrist.21 
All outcome measures were performed blindly by the same 
physiatrist before and after treatment, and the randomization 
was applied before the evaluation of  the patients.
Treatment program
All patients received one hour of  standard rehabilitation 
program 5 days a week, for 4 weeks.  Standard treatment 
included range of  motion, stretching, balance, and 
neurophysiologic exercises, resistance and gait training, and 
occupational therapy. This study reported results using the 
gait- or mobility-related outcome measures.
FES lower extremity cycle ergometry was accomplished 
using a motorized cycle-ergometer (MOTOmed VIVA2 
Reck ®). Patients were seated on a chair in front of  the cycle-
ergometer during treatment (Figure 1). 
A current-controlled eight-channel stimulator (Operation 
Manual RehaStim 2, RehaMove 2, Version 1,2 /2011-09 
HASOMED® GmbH) was used, and surface electrodes 
were applied in a bipolar configuration on both sides of  the 
Definition Right Left
Crouch
   Severe (>20º hip, knee, ankle)
   Moderate (5-20º hip, knee, 
ankle)
   Mild (< 5º hip, knee, ankle)
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   Flat
   Occasional heel-toe














   Worse
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Table 1: Visual Gait Analysis
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Table 2: Comparison of measurements before and after the treatment in the FES group
FES GROUP (n=9) M±SD
Parameters Pre-Treatment Post-Treatment P
GMFM-88 186,44±32,08 190,77±33,2 0,001*
WeeFIM 73,80±17,43 74,50±17,65 0,004*
6 minute walk test 117,83±86,2 148,72±106,5 0,001*































































































Adductor XV1 37,25±4,99 45,75±5,43 0,010*











pre- and post-treatment 
is significant (p<0.05)
T-test was used for 
comparison of pre- 
and post-treatment 
continuous measures 
within the group. A 
sign test was used 
for ordinal variables. 
M±SD:Means,Standard 
Deviations,  FES: 
Functional electric 
stimulation, GMFM 
-88: Gross Motor 
Function Measure-88, 
WeeFim: Functional 
İ n d e p e n d e n c e 
Measure for Children, 
M A S : M o d i f i e d 
Ashworth scale, 
SMK:selective motor 
control, XV1:as slow as 
possible, slower than 
the rate of natural drop 
of the limb segment 
under gravity ,XV3:as 
fast as possible, faster 
than the rate of natural 
drop of the limb 
segment under gravity
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SHAM  GROUP (n=9),M±SD
Parameters Pre-Treatment Post-Treatment P
GMFM-88 197,44±40,3 201,22±40,68 0,003*
WeeFIM 85,17±19,58 86,44±19,61 0,044*
6 minute walk test 168,55±80,92 217,11±92,50 0,001*































































































Adductor XV1 31,75±3,40 39,25±2,50 0,256










Table 3: Comparison of measurements before and after the treatment in the SHAM group
*Difference between pre- and 
post-treatment is significant 
(p<0.05)
T-test was used for comparison 
of pre- and post-treatment 
continuous measures within 
the group. A sign test was 
used for ordinal variables. 
M ± S D : M e a n s , S t a n d a r d 
Deviations,  FES: Functional 
electric stimulation, GMFM 
-88: Gross Motor Function 
Measure-88, WeeFim: 
Functional İndependence 
Measure for Children, 
MAS:Modified Ashworth 
scale, SMK:selective motor 
control, XV1:as slow as 
possible, slower than the 
rate of natural drop of the 
limb segment under gravity 
,XV3:as fast as possible, faster 
than the rate of natural drop 
of the limb segment under 
gravity
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CONTROL GROUP (n=7) n(%),M±SD
Parameters Pre-Treatment Post-Treatment P
GMFM-88 206,85±28,03 211,85±25,62 0,019*
WeeFIM 81,00±19,75 81,71±19,63 0,044*
6 minute walk test 184,78±133,01 209,00±129,84 0,025*































































































Adductor XV1 41.00±5,65 47,50±3,50 0,215










Table 4: Comparison of measurements before and after the treatment in the control group
*Difference between pre- and 
post-treatment is significant 
(p<0.05)
T-test was used for comparison 
of pre- and post-treatment 
continuous measures within 
the group. A sign test was 
used for ordinal variables. 
M ± S D : M e a n s , S t a n d a r d 
Deviations,  FES: Functional 
electric stimulation, GMFM 
-88: Gross Motor Function 
Measure-88, WeeFim: Functional 
İndependence Measure for 
Children, MAS:Modified 
Ashworth scale, SMK:selective 
motor control, XV1:as slow as 
possible, slower than the rate of 
natural drop of the limb segment 
under gravity ,XV3:as fast as 
possible, faster than the rate of 
natural drop of the limb segment 
under gravity
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quadriceps, hamstring, tibialis anterior, and gastrocnemius 
muscles with an algorithm inducing bilateral reciprocal leg 
cycling, at between 20-30 revolutions per minute (rpm). 
The size of  the electrodes (9x5 cm or 5x5 cm) were chosen 
according to the weight of  the patients and the area of  
the selected muscles. Rectangular biphasic pulses with a 
pulse width of  250-300 μs, the stimulus intensity up to a 
maximum of  100 mA, and a frequency ranged from 30 to 45 
Hz, stimulation phase: 7 seconds, ramp up: 2 seconds, ramp 
down: 2 seconds were adopted. A pilot FES cycling test was 
conducted for at least one minute to determine whether 
participants fulfilled the FES cycle and to determine the 
program to be applied throughout the therapy. All sessions 
consisted of  a 5-min warm-up of  passive cycling, a 20-min 
training of  FES-cycling, and a 5-min cool-down of  passive 
cycling. The patients received instructions from the same 
physiatrist. The patients were required not to participate 
voluntarily in the leg pedaling but to keep concentrating on 
the exercise.
All details were applied to the sham stimulus FES-cycling 
group in the same way but no stimulus was performed. 
Either FES-cycling or sham stimulus FES-cycling program 
was an additional 30 minutes program that was added to the 
standard treatment for 4 weeks, 5 times/week.
Statistical Analysis 
Data analysis was done by SPSS for Windows 15.0 packet 
program. Evaluation of  the variables for normal distribution 
was performed by Shapiro-Wilk Test and equal variance 
assumption was evaluated using Levene’s test. According 
to Levene’s test results, we used the data results associated 
with the “Equal variances assumed”. In descriptive statistics, 
the data were expressed as mean±standard deviation for 
continuous variables (GMFM, WeeFIM, 6-minute walk test, 
visual gait analysis, MTS XV1 and XV3 as well as SMC), 
and as frequencies and percentages (%) for nominal variables 
(MAS).  Two- way ANOVA was used to evaluate if  there 
was a statistically significant difference between pre- and 
post-therapy within groups as well as the importance of  
differences among the groups was assessed by ANOVA 
(bonferroni correction) test for continuous variables. Results 
were accepted as statistically significant if  p<0.05.  For our 
study no samples were calculated but Post-hoc power analysis 
was made. The data which forms the main hypothesis of  the 
study made up more than 80% of  the operating power in the 
power analyses and were found sufficient, while for some 
variables the operating power stayed below the intended 
level and was considered as a limitation for our study.
Results
Twenty-five patients with CP with bilateral lower limb 
involvement were included in the study. Eleven (44%) were 
girls and 14 (56%) were boys. Their ages were between 4 to 
11 years and the mean age was 6.0±1.7 years. No statistically 
significant difference in age (p=0.835) or gender (p=0.666) 
was found among the groups. 
Of  the 25 patients, 16 were able to ambulate with support while 
9 were ambulatory without support. No significant difference 
was found among groups concerning ambulation (p=0.376) 
and GMFCS system levels (p=0.392).
Outcome measures of  pre- and post-treatment results for 
groups were presented in Tables 2-4. 
There was no difference for bilateral knee and ankle MAS 
changes after treatment evaluated by Sign test (right knee 
p=0.350, left knee p=0.491, right ankle p=0.165, left ankle 
p=0.350). 
No statistically significant difference was obtained in terms 
of  changes in other parameters after treatment among 
groups (p>0.05) (Table 5). 
There weren’t any FES-cycling related side effects. The 
intensity levels of  FES stimulation were well tolerated.  The 
parents were willing to continue the study.
Discussion 
The clinical picture in CP may change in time due to the 
growth of  the child and other factors. Botulinum toxin 
type-A injections which are used commonly in spasticity 
treatment, recently are applied as a helpful complementary 
treatment among conventional methods 22, 23. In addition to 
this, it should not be used alone but should be combined with 
conventional therapies and surgical methods 24, 25.  However, 
there is insufficient evidence to ascertain which combination or 
alternative therapy would be the most useful in treating spasticity 
26. FES cycling programs have been reported to provide 
significant physical benefits including increased muscle size, 
reduced contractures, and spasticity, improved neurological 
and functional performance 7 .
The present study aimed to evaluate the effects of  FES-
cycling in patients with spastic diplegic CP who had 
undergone treatment with Botulinum toxin type A. FES was 
applied to bilateral quadriceps, hamstring, tibialis anterior 
and gastrocnemius muscles in this study. In the literature, 
the effects of  the botulinum toxin injection and FES-
cycling therapy were evaluated separately in children with 
cerebral palsy27, 28 . In our study, after the botulinum toxin 
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Table 5: Distribution and comparison of changes with treatment among 
the groups by using ANOVA
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a rehabilitation program in three different protocols lasting 
4 weeks. Post-injection rehabilitation is an integral part of  
the treatment. Although botulinum toxin administration 
is an effective treatment method for the reduction of  
spasticity in patients with cerebral palsy, it is not a single 
treatment method, it should be considered as a part of  the 
rehabilitation program. The reduction of  spasticity after 
injection provides patients with a therapeutic window. The 
purpose of  physiotherapy after the application is to maintain 
musculoskeletal system biomechanics and range of  motion, 
to improve muscle strength and endurance, to provide a 
balance between agonist and antagonist muscles, and to 
provide proprioceptive training3, 29, 30. 
Motor Function
In our study, there was no significant difference regarding 
the GMFCS levels before and after treatment among groups. 
All patients included in the study were able to ambulate 
(supported or unsupported) and their GMFM-88 levels 
were considerably high. While there were statistically 
significant differences between pre- and post-treatment 
values of  GMFM-88 levels for all groups, no significant 
difference among groups at the end of  4 weeks was found. 
Responsiveness of  the GMFM-88 has been shown on a 
2-month follow-up study comparing the effect of  the 
aerobic, anaerobic, and strengthening exercises 31 . The short 
term rehabilitation period in our study might show that 
GMFM-88 levels do not differ among groups.
6-Minute Walk Test
A 6-minute   walk   test,   a   simple,   sub-maximal   exercise 
test,   was   used   to   evaluate cardiopulmonary fitness 
in children with CP 32, 33 . Several factors may affect the 
results of  the test. Walking capacity may be reduced due 
to spasticity, impaired balance, and decreased muscle 
strength34,35. Balbaloglu et al. evaluated the walking speed and 
walking distance with a 6-minute walk test after application 
of  multilevel botulinum toxin injection to lower limbs of  
children with hemiplegic and diplegic CP and demonstrated 
significant improvements in all parameters 36 .  In our study, 
after the treatment, 6-minute walking distance increased in all 
groups, but these values did not reach statistically significant 
levels among the groups. Unlike the standard treatment 
group, the 2 groups who applied cycling performed aerobic 
exercise, we expected a significant change in the 6-minute 
walking test in these groups, but the small number of  patients 
may have caused no significant difference.
Visual Gait Analysis
Visual Gait analysis was used to evaluate the gait characteristics 
of  the patients. Statistically, significant amelioration was 
seen in the walking patterns such as an increase in ankle 
dorsiflexion, an improvement in foot contact, in all groups 
after the treatment but no difference was observed among 
the groups. In a recent study, Galen et al. applied FES to 
tibialis anterior muscle following botulinum toxin injections 
to gastrocnemius muscle to evaluate gait patterns in children 
with CP. They found an increase in ankle dorsiflexion at 
the end of  the combined intervention in most subjects, 
accompanied by an improvement in foot contact pattern 37 . 
Spasticity
MAS and MTS were used to evaluate the effects of  applied 
treatments on spasticity. In a study with 19 diplegic and 
4 hemiplegic patients, Hesse et al. stated that even after 4 
weeks of  botulinum toxin injection, patients could show 
more plantigrade foot posture and upright posture 38 . In a 
study by Dincer et al, patients were rehabilitated following 
botulinum toxin injections, and the spasticity was evaluated 
with MAS and joint range of  motion, and walking patterns 
were evaluated by physician observation. They recorded 
statistically significant improvements in all parameters 39 
In our study, there was a significant improvement in the 
bilateral ankle MAS level in the FES-cycling group after 
treatment. The other two groups presented improvements in 
bilateral ankle MAS levels, but this was statistically significant 
only on one side. But there was no statistically significant 
difference among groups. Moreover, there was a statistically 
significant difference in XV3 levels of  3 groups after 
treatment considering ankle MTS within the groups.  On the 
other hand, there was no statistically significant difference 
in XV3 measurements of  3 groups after treatment among 
the groups. Furthermore, adductor spasticity was evaluated 
by measuring the distance between knees (XV1, XV3). 
There was a statistically significant increase only in the FES-
cycling group after treatment. Sham and standard treatment 
groups showed clinical progress but it was not statistically 
significant. Mall et al. were also reported a significant increase 
in the distance between knees and a significant decrease in 
adductor spasticity following botulinum toxin injections to 
adductor and medial hamstring muscles 40 . 
Selective Motor Control
Selective motor control examination was performed to 
evaluate insufficiency in selective ankle dorsiflexion that 
affects the ambulation ability and functional gait pattern. 
SMC are significant factors that limit gross motor function 
in ambulant individuals with bilateral spastic CP. 41
After treatment, 2 children in the FES-cycling group showed 
one degree of  progress even it was not statistically significant 
and no difference was found in other groups. 
Functional Independence and Daily Living 
Activities
WeeFIM is proved to be a safe and valid measure for children 
between 6 months to 12 years old13, 42 . In our study, statistically 
significant improvements were observed in WeeFIM scores 
of  all 3 groups after the rehabilitation period, but there was 
no statistically significant difference among groups. Larger 
scale studies with longer follow-up are needed to determine 
the true impact of  these methods.
The limitations of  our study were relatively small sample 
size, and short study period because of  the presence of  
excessive exclusion criteria which might lead to exclusion 
of  a large proportion of  patients. In the study, it was not 
sufficient to have the diagnosis of  cerebral palsy, it was also 
required to meet the criteria for FES application. Since there 
is no relevant prevalence data in the literature, the study was 
planned as “hospitalized patients within 1 year.” 
In conclusion, all groups showed statistically significant 
improvements in motor function, walking pattern, spasticity, 
daily living activities, and aerobic capacity in patients with CP 
following the rehabilitation period. Although FES-cycling 
demonstrated no superiority over the other approaches and 
provided no additional benefit to the results, FES appears 
to be safe and well-tolerated in children with CP, at least 
as much as standard exercise treatment, studies with larger 
sample sizes and longer intervention times are needed to 
reveal accurate evidence and time and cost-effectiveness 
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before recommending the intervention.
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